Therapeutic targeting of E2F inhibits stemness of salivary gland mucoepidermoid carcinoma
Cancer Treatment and Research Communications · 2026 · 49 · 101413
DOI: 10.1016/j.ctarc.2026.101413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Jaqueline V Vanini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, State of Sao Paulo Research Foundation, Coordination for the improvement of Higher Education Personnel.
Abstract (Originalsprache)
The E2F family of transcription factors plays essential roles in cell cycle regulation, DNA damage response, apoptosis, senescence, glucose metabolism, and angiogenesis. Although E2F pathway alterations were identified across multiple cancers, its role in salivary gland tumorigenesis remains elusive. Given the mechanistic role of E2F in cancer stemness, this pathway represents a promising therapeutic target for salivary malignancies. The purpose of this study was to evaluate the function of E2F1 and E2F4 in the stemness of salivary gland mucoepidermoid carcinoma (MEC), and to test whether pharmacologic inhibition of E2F ablates cancer stem cells (CSC) in MEC. Evaluation of a tissue microarray (TMA) of human MEC samples showed that E2F1 and E2F4 were overexpressed in MECs compared with control salivary glands, where their expression was restricted to ductal cells. CSCs showed higher expression of E2F1 and E2F4 compared to non-CSCs in 3 human MEC cell lines (UM-HMC-1,-3A,-3B). Therapeutic inhibition of E2F with HLM006474 induced expression of p53 and p21 while inhibiting expression of the stemness markers Bmi-1 and ALDH. Notably, the fraction of CSC (ALDHhighCD44high) was significantly reduced by HLM006474 in vitro, and in MEC tumor xenografts in vivo. Collectively, these data demonstrate that E2F inhibits stemness in mucoepidermoid carcinoma and suggest that patients with salivary gland malignancies might benefit from therapeutic inhibition of E2F.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA.
- Department of Stomatology, School of Dentistry, University of São Paulo, SP, Brazil.
- Department of Periodontics & Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA.
- Head and Neck Surgery, Medical School, University of São Paulo, SP, Brazil.
- Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA; Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann…
Förderung
- NIDCR NIH HHS
- State of Sao Paulo Research Foundation
- Coordination for the improvement of Higher Education Personnel
- National Institutes of Health
- National Institute of Dental and Craniofacial Research
- National Council for Scientific and Technological Development
Zitieren
APA
Vanini, J. V., Figueredo, J. M., Nör, F., Warner, K. A., Cheladyn, B., Tsuboi, R., Pobocik, A. M., Polverini, P. J., de Matos, L. L., Nunes, F. D., & Nör, J. E. (2026). Therapeutic targeting of E2F inhibits stemness of salivary gland mucoepidermoid carcinoma. Cancer Treatment and Research Communications, 49, 101413. https://doi.org/10.1016/j.ctarc.2026.101413
Vancouver
Vanini JV, Figueredo JM, Nör F, Warner KA, Cheladyn B, Tsuboi R, et al. Therapeutic targeting of E2F inhibits stemness of salivary gland mucoepidermoid carcinoma. Cancer Treatment and Research Communications. 2026;49:101413. doi:10.1016/j.ctarc.2026.101413
BibTeX
@article{Vanini2026,
author = {Vanini, Jaqueline V and Figueredo, José M and Nör, Felipe and Warner, Kristy A and Cheladyn, Brennan and Tsuboi, Ririko and Pobocik, Andrea M and Polverini, Peter J and de Matos, Leandro L and Nunes, Fabio D and Nör, Jacques E},
title = {Therapeutic targeting of E2F inhibits stemness of salivary gland mucoepidermoid carcinoma},
journal = {Cancer Treatment and Research Communications},
year = {2026},
volume = {49},
pages = {101413},
doi = {10.1016/j.ctarc.2026.101413}
}
EUVIMED